SCHEMBL6672244

SCHEMBL6672244

ON=C(COCc1ccccc1)c1ccc2ccccc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 2/20 0.46
GRIN2B Q13224 2/20 0.46
ALOX5 P09917 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
POLB P06746 1/20 0.42
PPARG P37231 1/20 0.42
NCOA2 Q15596 1/20 0.42
NCOA1 Q15788 1/20 0.42
NCOA3 Q9Y6Q9 1/20 0.42
TSHR P16473 1/20 0.40
BDKRB2 P30411 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
MAPT P10636 4/20 0.39
KDM4E B2RXH2 3/20 0.39
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9377338 0.82 TSHR (0.50) KMT2APOLBTSHRMAPTKDM4E
SCHEMBL6669961 0.82 HDAC8 (0.47) GRIN1GRIN2BHDAC8KMT2AMEN1
SCHEMBL7908828 0.81 NR4A1 (0.55) KMT2AMEN1CYP1A2CYP2C19MAPT
SCHEMBL6672136 0.78 HDAC8 (0.49) GRIN1GRIN2BHDAC8KMT2AMEN1
SCHEMBL6667919 0.75 HDAC8 (0.46) GRIN1GRIN2BHDAC8KDM4EALDH1A1
SCHEMBL6667377 0.74 HDAC8 (0.54) GRIN1GRIN2BHDAC8KMT2AMEN1
SCHEMBL29183337 0.73 SMN1; SMN2 (0.56) POLBKDM4EALDH1A1HTTCES2
SCHEMBL7440698 0.73 GAA (0.53) GRIN1GRIN2BHDAC8KMT2AMEN1
SCHEMBL7440691 0.73 GAA (0.53) GRIN1GRIN2BHDAC8KMT2AMEN1
SCHEMBL4308698 0.72 HDAC8 (0.53) GRIN1GRIN2BHDAC8KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1133467-B1 ION CHANNEL MODULATING AGENTS NEUROSEARCH AS (DK) 2004-09-15 EP claimed
US-20040248099-A1 Use of intermediate -conductance potassium channels and modulators for diagnosing and treating diseases having disturbed keratinocyte activity SWITCH BIOTECH AKTIENGESELLSCHAFT (DE) 2004-12-09 US disclosed